Search clinical trials for: IIV4c

Total 21 results

Seqirus

Completed

Safety and Immunogenicity of an MF59-Adjuvanted Influenza Vaccine in Older Adults

Influenza | Human

United States
China National Biotec Group Company Limited
Peking University; Hunan Provincial Center for Disease Control and Prevention; Guizhou Center for Disease Control and Prevention and other collaborators

Completed

Evaluation of Safety and Immunogenicity of Combined Immunization of PPV23 and IIV4

Pneumonia, Pneumococcal | Influenza, Human

China
Vanderbilt University Medical Center
Duke University; Centers for Disease Control and Prevention; Children's Hospital...

Completed

Influenza Vaccine Feasibility Study in Children With Persistent Asthma

Asthmatic

United States
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.; Sichuan Center for Disease... and other collaborators

Completed

Evaluation of Immunogenicity and Safety of Combined Immunization of COVID-19 Vaccine (Produced in Beijing) and PPV23 / IIV4

Covid19 | Pneumonia, Pneumococcal | Influenza, Human

China
China National Biotec Group Company Limited
Wuhan Institute of Biological Products Co., Ltd; Henan Center for Disease Control... and other collaborators

Active, not recruiting

Evaluation of Immunogenicity and Safety of Combined Immunization of COVAX (Produced in Wuhan) and PPV23 / IIV4

Pneumonia, Pneumococcal | Influenza, Human | COVID-19 Pneumonia

China
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination and Infection (SLVP030)

Healthy | Influenza

United States
China National Biotec Group Company Limited
Xiangya Hospital of Central South University; Beijing Institute of Biological... and other collaborators

Recruiting

Immunogenicity and Safety of BBIBP-Corv Coadministered With PPV23 and IIV4 in Hemodialysis Population

COVID-19 | Hemolysis

China
Duke University
Johns Hopkins University; Centers for Disease Control and Prevention; Children...

Completed

Simultaneous mRNA COVID-19 and IIV4 Vaccination Study

Quality of Life | Adverse Drug Event | Injection Site Reaction | Systemic Reaction

United States
Protein Sciences Corporation
Syneos Health; Department of Health and Human Services

Completed

Safety and Immunogenicity of Flublok Quadrivalent vs IIV4 in Adults 18-49 Years of Age

Influenza

United States
Sanofi Pasteur, a Sanofi Company

Completed

Surveillance Study to Assess the Safety of Flublok Quadrivalent (Influenza Vaccine) in Pregnant Women and Their Offspring (VAP00007)

Influenza

United States
Marshfield Clinic Research Foundation
Centers for Disease Control and Prevention

Active, not recruiting

Randomized Influenza Vaccine Evaluation of Immune Response (RIVER)

Influenza

United States
Huazhong University of Science and Technology

Unknown

Infrahepatic Inferior Vena Cava Clamping Versus Selective Hepatic Vascular Exclusion Involving the Portal Triad Clamping

Liver Cirrhosis | Liver Neoplasms

China
Sanofi Pasteur, a Sanofi Company

Completed

Study Describing the Immunogenicity and Safety of Quadrivalent Recombinant Influenza Vaccine (RIV4) Versus a Licensed Quadrivalent-inactivated Influenza Vaccine (IIV4) (Fluarix® Quadrivalent) in Participants 18 Years of Age and Older in South Korea

Influenza (Healthy Volunteers)

Korea, Republic of
VaxInnate Corporation
Department of Health and Human Services; Accelovance

Unknown

Study of the Immunogenicity and Safety of a Quadrivalent Influenza Vaccine (VAX2012Q) in Adults 18-64 Years

Influenza

United States
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID); National Institutes...

Completed

The Effects of Attenuated Versus Inactivated Flu Vaccine in Twin Sets (FLU-TW)

Influenza

United States
Sanofi Pasteur, a Sanofi Company

Terminated

Study With Quadrivalent Recombinant Influenza Vaccine (RIV4) Compared With Egg-Based Quadrivalent Influenza Vaccine (IIV4) in Participants Aged 3 to 8 Years

Influenza Immunization

United States, Denmark, Poland, Spain
Kaiser Permanente
Seqirus

Recruiting

Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years

Influenza | Community-acquired Pneumonia | Cardiovascular Events

United States
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Comparison of Immune Responses to Influenza Vaccine In Adults of Different Ages (SLVP015 2007-2017)

Influenza

United States
Duke University
Centers for Disease Control and Prevention; Kaiser Permanente

Completed

Fever After Simultaneous Versus Sequential Vaccination in Young Children

Fever | Febrile Seizure | Fever After Vaccination

United States
Duke University
Johns Hopkins University; Centers for Disease Control and Prevention

Completed

Simultaneous RZV and aIIV4 Vaccination

Quality of Life | Pain | Adverse Drug Event | Injection Site Reaction

United States
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Effects of Aging on Primary and Secondary Vaccine Responses in a 15-Year Longitudinal Cohort (SLVP033)

Hepatitis A | Influenza | Healthy Adults | Typhoid

United States

Search clinical trials for: IIV4c

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Peru

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations